Singapore has officially begun the transition to the electronic Common Technical Document (eCTD), a major step toward a more streamlined regulatory environment in the Asia-Pacific region. Key milestones include test submissions starting now, with full acceptance of eCTD dossiers from Q2 2026. The initial launch will cover new drug applications, generic drug applications, and drug master file applications. 

Download our flyer to explore the key highlights and see how Asphalion can support your transition with expert eCTD services. 

If you require any assistance, you can contact us at info@asphalion.com⁠⁠⁠⁠⁠⁠⁠